Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company that is focused on developing targeted alpha therapeutics for the treatment of cancer. The company's mission is to improve the lives of cancer patients by developing innovative therapies that are more effective and less toxic than current treatments. Fusion Pharmaceuticals is committed to using cutting-edge science and technology to create therapies that target cancer cells while sparing healthy tissue. The company is headquartered in Toronto, Canada.